GFM
BNTX icon

GF Fund Management’s BioNTech BNTX Stock Holding History

GF Fund Management’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$225K Buy
2,414
+144
+6% +$13.6K ﹤0.01% 264
2026
Q1 		$202K Buy
2,270
+283
+14% +$29.1K ﹤0.01% 283
2025
Q4 		$189K Sell
1,987
-177
-8% -$17.8K ﹤0.01% 300
2025
Q3 		$213K Sell
2,164
-350
-14% -$37.4K ﹤0.01% 287
2025
Q2 		$268K Hold
2,514
– – 0.01% 298
2025
Q1 		$229K Buy
2,514
+453
+22% +$50.7K 0.01% 314
2024
Q4 		$235K Buy
+2,061
New +$235K 0.01% 275

Other funds holding BNTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
GP
GSK plc London $602M AUM

GF Fund Management's BNTX Position: Q2 2026 in Review

GF Fund Management increased its BioNTech (BNTX) stake by 6.3% in Q2 2026, buying an estimated $13.6K and bringing the position to 2,414 shares worth $225K. The position accounts for ﹤0.01% of the portfolio, ranked #264.

GF Fund Management first reported a position in BNTX in Q4 2024 and has held it in 7 quarters since. The position peaked at $268K in Q2 2025. 283 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

  • GF Fund Management held 2,414 shares of BioNTech worth $225K as of Q2 2026.
  • GF Fund Management bought 144 BioNTech shares in Q2 2026, an estimated $13.6K.
  • BioNTech made up ﹤0.01% of GF Fund Management's portfolio in Q2 2026, its #264 holding.
  • GF Fund Management first reported a position in BioNTech in Q4 2024 and has held it in 7 quarters since.
  • GF Fund Management's BioNTech position peaked at $268K in Q2 2025.
  • 283 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on GF Fund Management's 13F filing for Q2 2026, filed 7 Aug 2026.